F

Forward Ventures

10 employees

Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.

Investor insights

Sectors invested in

Biotechnology29
Health Care27
Pharmaceutical16
Biopharma14
Medical12
Therapeutics9
TargeGen4
Inc. is a privately held biopharmaceutical company based in San Diego4
CA. TargeGen primarily develops small molecule kinase inhibitors for applications in oncology and inflammatory diseases.4
Clinical Trials4
Web Development4
Women's4
minimally invasive treatment4
diagnostic imaging4
Breast Tumors4
Breast Care4
Surgical Alternatives4
radiology4
interventional radiology4
Cryoablation4

Funding rounds participated in

$23M sweet spot round size

Most of their 59 investments are in rounds between $17M and $34M

Investor type

Incubator

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Venture Capital Life Sciences

Date founded

1993

Investments made

X

Xanadu raised $100M on November 9, 2022

Investors: Capricorn Venture Partners, Alumni Ventures Group, Pegasus Tech Ventures, Porsche Automobil Holding SE, Bessemer Venture Partners, Georgian Partners and Forward Ventures

S

SpotQA raised $3.3M on August 20, 2019

Investors: Forward Partners, Crane Venture Partners, Acequia Capital and Forward Ventures

V

Viracta Therapeutics, Inc. raised $18M on April 4, 2017

Investors: NantKwest (NASDAQ: NK) and Forward Ventures

S

Syndax Pharmaceuticals raised $80M on August 24, 2015

Investors: Jennison Associates LLC, Delos Capital, RMI Partners, MPM Capital, Domain Associates, OrbiMed Advisors and Forward Ventures

P

PINT, Inc. raised $12M on September 11, 2013

Investors: Forward Ventures

S

Syndax Pharmaceuticals raised $27M on August 27, 2013

Investors: MPM Capital, Domain Associates, RMI Partners and Forward Ventures

A

Ambit Biosciences raised $50M on November 6, 2012

Investors: Gimv, Aisling Capital, OrbiMed Advisors, Radius Ventures, Apposite Capital and Forward Ventures

V

Viracta Therapeutics, Inc. raised $13M on March 12, 2012

Investors: Aberdare Ventures, Lilly Ventures and Forward Ventures

P

PINT, Inc. raised $15M on August 29, 2011

Investors: Forward Ventures

A

Ambit Biosciences raised $30M on June 10, 2011

Investors: Gimv, NovaQuest Capital Management, Apposite Capital, OrbiMed Advisors, Radius Ventures and Forward Ventures

FAQ